REVOLAX with Lidocaine is a CE Marked Medical Device

Fox Group International Ltd today confirmed that the CE mark for REVOLAX with Lidocaine has been renewed, meaning that it is deemed fit for purpose and meets all the legal and regulatory safety requirements to be sold in the UK and the EU.

At Fox Group, we pride ourselves on our broad range of high-quality dermal fillers that provide excellent results for both our customers and their client alike.

As the Nation’s Favourite Dermal Filler, REVOLAX has been praised by medical professionals across the UK for its high-quality properties, advanced cross-linked technology and malleable consistency. 

The REVOLAX range consists of three different viscosities, REVOLAX Fine, REVOLAX Deep and REVOLAX Sub Q, which are designed to achieve the best results for different areas of the face and are all available both with and without the addition of Lidocaine. 

REVOLAX manufacturer, Across Co., Ltd confirms; “We hereby announce that Fox Group International Ltd is our exclusive UK distributor and the only approved channel to purchase REVOLAX products within the UK.”

Michael Foxley, CEO of Fox Group International states “We are delighted that the REVOLAX with Lidocaine CE has been renewed. At Fox Group, our customers are always at the heart of what we do, and I personally would like to thank all our customers for their support during this time.”

Both REVOLAX with Lidocaine and REVOLAX Non-Lidocaine will be exclusively available to purchase from and starting 04/11/20

All Fox Group websites offer next working day delivery as standard, have a dedicated team of on-site pharmacists and customer service operatives ready to answer any queries you may have, and a promise to provide only the highest quality dermal fillers at the most affordable prices.